• Je něco špatně v tomto záznamu ?

Prognostic significance of ischemia modified albumin after percutaneous coronary intervention

Dusek J, St'ásek J, Tichý M, Bis J, Gregor J, Vojácek J, Masín V, Polanský P, Brtko M, Cernohorský D.

. 2006 ; 367 (1-2) : 77-80.

Jazyk angličtina Země Nizozemsko

Perzistentní odkaz   https://www.medvik.cz/link/bmc07521923
E-zdroje Online

NLK ScienceDirect (archiv) od 1993-01-01 do 2009-12-31

Ischemia modified albumin (IMA) is a new biochemical marker of ischemia. IMA levels rise in patients who develop ischemia during percutaneous coronary intervention (PCI). It is unclear whether IMA elevations correlate with PCI variables. The possible prognostic value of post-PCI IMA elevation has not yet to be studied. METHODS: We studied 60 patients (mean age 61 years; 51 male) who underwent successful elective single-vessel PCI for the management of stable angina pectoris. IMA levels were measured and compared with PCI variables and target lesion revascularization rate. The median post-PCI follow up is 46 months (CI 44.6 to 47.7). RESULTS: We found that the only variable related to post-PCI IMA levels was periprocedural dissection of target vessel (147.6 vs. 141.1 kU/l, p=0.035). No correlation between high and low balloon inflation pressure (143.6 vs. 141.6 kU/l, p=0.64), short and long inflation pressure (141.5 vs. 143.6 kU/l, p=0.17), with and without stent placement (143.7 vs. 141.3 kU/l, p=0.93) was found. IMA level more then 130 kU/l was associated with higher frequency of target lesion revascularization at nearly 4-years follow-up (p=0.026). CONCLUSION: Post-PCI IMA elevation is associated with higher target lesion revascularization.

000      
00000naa 2200000 a 4500
001      
bmc07521923
003      
CZ-PrNML
005      
20111210133028.0
008      
090423s2006 ne e eng||
009      
AR
040    __
$a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a ne
100    1_
$a Dušek, Jaroslav. $7 xx0190321
245    10
$a Prognostic significance of ischemia modified albumin after percutaneous coronary intervention / $c Dusek J, St'ásek J, Tichý M, Bis J, Gregor J, Vojácek J, Masín V, Polanský P, Brtko M, Cernohorský D.
314    __
$a First Department of Internal Medicine, University Hospital Hradec Králové, Czech Republic. dusek@fnhk.cz
520    9_
$a Ischemia modified albumin (IMA) is a new biochemical marker of ischemia. IMA levels rise in patients who develop ischemia during percutaneous coronary intervention (PCI). It is unclear whether IMA elevations correlate with PCI variables. The possible prognostic value of post-PCI IMA elevation has not yet to be studied. METHODS: We studied 60 patients (mean age 61 years; 51 male) who underwent successful elective single-vessel PCI for the management of stable angina pectoris. IMA levels were measured and compared with PCI variables and target lesion revascularization rate. The median post-PCI follow up is 46 months (CI 44.6 to 47.7). RESULTS: We found that the only variable related to post-PCI IMA levels was periprocedural dissection of target vessel (147.6 vs. 141.1 kU/l, p=0.035). No correlation between high and low balloon inflation pressure (143.6 vs. 141.6 kU/l, p=0.64), short and long inflation pressure (141.5 vs. 143.6 kU/l, p=0.17), with and without stent placement (143.7 vs. 141.3 kU/l, p=0.93) was found. IMA level more then 130 kU/l was associated with higher frequency of target lesion revascularization at nearly 4-years follow-up (p=0.026). CONCLUSION: Post-PCI IMA elevation is associated with higher target lesion revascularization.
650    _2
$a albuminy $x metabolismus $7 D000418
650    _2
$a balónková koronární angioplastika $7 D015906
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a lidé $7 D006801
650    _2
$a ischemie $x diagnóza $x krev $x metabolismus $x terapie $7 D007511
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a patologická angiogeneze $x krev $x patologie $7 D009389
650    _2
$a prognóza $7 D011379
650    _2
$a financování organizované $7 D005381
700    1_
$a Šťásek, Josef, $d 1955- $7 xx0063485
700    1_
$a Tichý, Miloš, $d 1941- $7 xx0112487
700    1_
$a Bis, Josef $7 xx0071045
700    1_
$a Gregor, Jaroslav $7 xx0081909
700    1_
$a Vojáček, Jan, $d 1947- $7 jn20000402578
700    1_
$a Mašín, Vladimír $7 xx0061146
700    1_
$a Polanský, Pavel $7 xx0101818
700    1_
$a Brtko, Miroslav $7 xx0035884
700    1_
$a Černohorský, Dušan $7 xx0101390
773    0_
$w MED00009464 $t Clinica chimica acta $g Roč. 367, č. 1-2 (2006), s. 77-80 $x 0009-8981
910    __
$a ABA008 $b A 2555 $y 9
990    __
$a 20090312170439 $b ABA008
991    __
$a 20111018143753 $b ABA008
999    __
$a ok $b bmc $g 645012 $s 497928
BAS    __
$a 3
BMC    __
$a 2006 $b 367 $c 1-2 $d 77-80 $i 0009-8981 $m Clinica chimica acta $x MED00009464
LZP    __
$a 2009-B1/vtme

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...